[The role of adipokines and insulin resistance in the pathogenesis of nonalcoholic fatty liver disease]
- PMID: 20498498
[The role of adipokines and insulin resistance in the pathogenesis of nonalcoholic fatty liver disease]
Abstract
Nonalcoholic fatty liver disease (NAFLD) develops in 17-33% of the population of developed countries. The incidence of NAFLD is constantly growing due to the increasing prevalence of obesity. It is estimated that one third of subjects with NAFLD suffer from nonalcoholic steatohepatitis (NASH) and 15% of them develop liver cirrhosis within a five-year period. In recent years this important complication of obesity became the subject of numerous studies. It, the pathogenesis of NAFLD is still unclear. A key role in the development of this disease was attributed to insulin resistance. Hormones and cytokines produced by adipose tissue called adipokines may be a link between obesity, insulin resistance, and NAFLD. However, it is well known that increased levels of adipokines such as TNF-alpha, IL-6, and resistin and a decreased level of adiponectin augment inflammation in the liver. Further studies are necessary to explain the roles of leptin, visfatin, retinol binding protein-4, omentin, and vaspin in the pathogenesis of NAFLD. The aim this paper is to introduce new areas of study on the pathogenesis of NAFLD.
Similar articles
-
Adipokines in nonalcoholic fatty liver disease.Metabolism. 2016 Aug;65(8):1062-79. doi: 10.1016/j.metabol.2015.11.006. Epub 2015 Nov 24. Metabolism. 2016. PMID: 26725002 Review.
-
Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.World J Gastroenterol. 2014 Dec 28;20(48):18070-91. doi: 10.3748/wjg.v20.i48.18070. World J Gastroenterol. 2014. PMID: 25561778 Free PMC article. Review.
-
Retinol-binding protein 4 and new adipocytokines in nonalcoholic fatty liver disease.Curr Pharm Des. 2010 Jun;16(17):1921-8. doi: 10.2174/138161210791208938. Curr Pharm Des. 2010. PMID: 20370670 Review.
-
Adipokines and cytokines in non-alcoholic fatty liver disease.Aliment Pharmacol Ther. 2008 Mar 1;27(5):412-21. doi: 10.1111/j.1365-2036.2007.03586.x. Epub 2007 Dec 10. Aliment Pharmacol Ther. 2008. PMID: 18081738
-
Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance.Obes Surg. 2006 Sep;16(9):1118-25. doi: 10.1381/096089206778392149. Obes Surg. 2006. PMID: 16989692
Cited by
-
Saroglitazar Deactivates the Hepatic LPS/TLR4 Signaling Pathway and Ameliorates Adipocyte Dysfunction in Rats with High-Fat Emulsion/LPS Model-Induced Non-alcoholic Steatohepatitis.Inflammation. 2019 Jun;42(3):1056-1070. doi: 10.1007/s10753-019-00967-6. Inflammation. 2019. PMID: 30737662
-
Serum vaspin level as a predictive indicator in the amelioration of fatty liver and metabolic disturbance in patients with severe obesity after laparoscopic vertical banded gastroplasty.Medicine (Baltimore). 2017 Jul;96(30):e7498. doi: 10.1097/MD.0000000000007498. Medicine (Baltimore). 2017. PMID: 28746192 Free PMC article.
-
Cytokine modulation by etanercept ameliorates metabolic syndrome and its related complications induced in rats administered a high-fat high-fructose diet.Sci Rep. 2022 Nov 23;12(1):20227. doi: 10.1038/s41598-022-24593-9. Sci Rep. 2022. PMID: 36418417 Free PMC article.
-
The interplay between Th17 and T-regulatory responses as well as adipokines in the progression of non-alcoholic fatty liver disease.Clin Exp Hepatol. 2017 Sep;3(3):127-134. doi: 10.5114/ceh.2017.68466. Epub 2017 Jun 21. Clin Exp Hepatol. 2017. PMID: 29062902 Free PMC article. Review.
-
Ping-tang Recipe () improves insulin resistance and attenuates hepatic steatosis in high-fat diet-induced obese rats.Chin J Integr Med. 2012 Apr;18(4):262-8. doi: 10.1007/s11655-012-1023-0. Epub 2012 Mar 30. Chin J Integr Med. 2012. PMID: 22457136
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources